NEW YORK (GenomeWeb News) – Liverpool, UK-based Biofortuna announced today that it has extended an exclusive distribution agreement with Abbott.

Under the new agreement, Abbott will distribute Biofortuna's SSPGo range of freeze dried HLA typing kits in France, Spain, Portugal, and the Benelux countries. With this new agreement, Abbott now has exclusive rights to distribute the kits, along with the Verdict interpretation software, in all global territories.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.